We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Warns New Jersey Drugmaker for Repeat Violations
FDA Warns New Jersey Drugmaker for Repeat Violations
The FDA issued a warning letter to Nationwide Laboratories over repeated CGMP violations at its Iselin, New Jersey facility, including failing to monitor its contractors.